The FDA just published a new, draft guidance document on good manufacturing practices (cGMP) for drugs. This document is intended to address the frequent data integrity issues found during FDA inspection of pharmaceutical and API manufacturing sites.
This draft guidance contains clarifications and definitions for the terms like:
It also contains the draft FDA recommendations regarding computer system:
Do you need more help implementing these recommendations in your organization? Talk to our CSV experts about how you can update your practices for compliance.